she was well enough to go back to her job at wire manufacturer Peter Stubs in Warrington and operate the switchboard.She stayed with the firm for 43 years before she retired.She said: 'I won them over because I could do everything in my job that I used to do thanks to my training...
Methotrexate (MTX) is the anchor disease modifying anti-rheumatic drug (DMARD) in the management of rheumatoid arthritis (RA) and other immune mediated chronic inflammatory disorders. In RA, it is the most commonly used DMARD and the first one to be chosen [1,2] due to its efficacy, safety...
Being able to predict response to first-line DMARDs, has been one of the main challenges in RA management for over two decades [12] and it is a good example of the increasingly appealing concept of personalized therapy, that is, choosing the drug of most benefit for a particular patient. ...